Molecular Partners Ag (MOLN) Change in Cash (2020 - 2026)
Molecular Partners Ag (MOLN) posted quarterly Change in Cash of -$23499.4 for Q1 2026, down 220.74% year-on-year from $19462.2 in Q1 2025, and down 100.1% on a QoQ basis from $23.5 million in Q4 2025.
Molecular Partners Ag (MOLN) Change in Cash (2020 - 2026) Analysis & Trends
Molecular Partners Ag (MOLN) has reported Change in Cash for 7 consecutive years, with -$23499.4 the latest figure, recorded in Q1 2026.
- Quarterly Change in Cash fell 220.74% year-over-year to -$23499.4 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.7 million (up 23474.75% YoY) and the FY2025 annual result came in at $23.5 million, up 699.21% from the prior year.
- Change in Cash declined to -$23499.4 in Q1 2026 per MOLN's latest filing, from $23.5 million in the prior quarter.
- Over the last five years, Change in Cash for MOLN reached as high as $44.7 million in Q2 2022 and fell as low as -$44.7 million in Q3 2022.
- A 5-year average of $1.1 million and a median of $10324.5 in 2024 frame the typical range for Change in Cash.
- The largest YoY upside for Change in Cash was 1539.71% in 2025 against a maximum downside of 1308.69% in 2025.
- Year by year, Change in Cash stood at $16.7 million in 2022, then slumped by 238.78% to -$23.2 million in 2023, then surged by 108.05% to $1.9 million in 2024, then surged by 1155.0% to $23.5 million in 2025, then tumbled by 100.1% to -$23499.4 in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered -$23499.4, $23.5 million, and -$22.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Molecular Partners Ag | 147.97 Mn | 147.97 Mn | - | -23,499.44 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23,499.44 |
| Dec 31, 2025 | 23.47 Mn |
| Sep 30, 2025 | -22.61 Mn |
| Jun 30, 2025 | 21.84 Mn |
| Mar 31, 2025 | 19,462.16 |
| Sep 30, 2024 | 1.87 Mn |
| Jun 30, 2024 | -1.79 Mn |
| Mar 31, 2024 | 1,186.93 |
| Dec 31, 2023 | -23.24 Mn |
| Sep 30, 2023 | 27.95 Mn |
| Jun 30, 2023 | -27.46 Mn |
| Mar 31, 2023 | -15,153.57 |
| Dec 31, 2022 | 16.75 Mn |
| Sep 30, 2022 | -44.66 Mn |
| Jun 30, 2022 | 44.71 Mn |
| Mar 31, 2022 | 76,019.64 |
| Dec 31, 2021 | -67.08 Mn |
| Sep 30, 2021 | 7.74 Mn |
| Jun 30, 2021 | -7.82 Mn |
| Mar 31, 2021 | -30,471.93 |